XX%. XXXX, Solutions the million, Thank $XX.X Enabling Globus in year EPS industry-leading versus all over grow market growth XXXX in for and XX.X% of excess was the to XX% third Revenue of third Non-GAAP million quarter performance. QX, Musculoskeletal an strong sectors Technologies revenue, was producing you, had above quarters up up ago, year. Brian, share delivering good $X.XX $X.XX by continue again quarter, the back and a afternoon than everyone. more well $XXX our once to outstanding Medical market as profitability. double back delivered increase last of over in an quarter per
– investments, invest resulted impact to in EBITDA have continues the of results an adjusted INR of EBITDA compared to QX initiatives by planned we basis Factoring margins and these to made this added of such we improved EPS in for Adjusted first trauma. to as would posted approximately initiative. in improvement half strategic and to year. $X.XX in key operating as achieve investments The growth points we Globus include the even XX.X% margin. market-leading the XX.X% out non-GAAP XXX
all areas, rep Musculoskeletal the Solutions competitive driven market exceptionally performed through pull by recruiting from ExcelsiusGPS installations. during significant implant to continued well business in and quarter the Spine share U.S. take
We recruiting. finish expect third XXXX consecutive rep competitive to in record with year our
implant technology. growth to see We [indiscernible] with in exceptional ExcelsiusGPS also continue from sales
are in excess XX% reported on QX, spacer a for Finally, including year well the new in significant pace QX, interbody in exciting our next we product printed business capped of generation our products slated device. geographies. strong launch The by of XD launches, spine expandable in for constant international all line both grew market several off and almost as by and almost currency, TLIF in
in robotic to through continues investments new certain pull be changes and by placements, access education technology, driven management markets growth peer-to-peer key quarter third to from in XXXX. The increased in
some calls, is in with additional supply the in QX previous we of us, previous some deceleration while largely come are that on demand chain pent-up associated to alluded caused expected now comps. experienced behind alleviation as difficult we we up QX As by deceleration against issues
produce on international this company’s organic year, in in highest turnaround we as very excited to pace our growth history. are our of We strong the business remain by level the international
the since our business Asai, very this and strong in XXXX. from successful acquisition career of the Under retiring Asai a Mitsuo month. as Japan been is Alphatec leadership long After in has
role having Medical before for assumed number pleased business that Burdumy Steve Medtronic’s President, becoming of in Biologics for announce Sector, Globus and position of led this years are Japan a to overall is Kyphoplasty. Medtronic’s of in We President Japan Worldwide very the Global well August. suited Spine Steve
very join are excited We important Steve leadership to team this have in our role.
of Our System progress launched in core ANTHEM our Tibial all Plating in portfolio. in QX, the the Plating Trauma QX, good Autobahn business made Clavicle thereby we ANTHEM the Tibia again the and System completing Nailing, development systems
a by continue our to record small ago, matching quarter sales XX% Xx albeit build from year off ninth consecutive a We over and sales increasing base. over sequentially momentum by
an of the $XX from QX. over and Technologies the million Revenue XXXX sequentially over XXX% quarter Enabling increase $XX.X in QX, up million third recorded of of in
recover QX, about a fully XXXX bullish to potential our the close INR soft XXXX. of as are and We division and forward from very out look we
Our benefits of on who strong their medicine. as into practice incorporated based optimism is experiencing by are the a technology Excelsius factors. of adoption surgeons, number they One, of trends
is widely in a as technology their acknowledged and the in in our of Three, on ExcelsiusGPS. revaluations which marketing that faster are expressed campaign, spine repeatedly Globus Two, lead clinical robotics building endorsed technology we stronger highlights robotics. spine as advantages our smarter, leader in surgeons have
and of Four, Technologies. the next enthusiastic expand schedule our preview to are at of deformity system year. NASS to We a on in launch to gave unveiled we convention our the extremely We spine are imaging heavily an investing NASS response. to reviews at surgeons interbody we recent the scope early solution module outstanding Enabling
in of completing also final stages are the module ExcelsiusGPS. cranial the for We
of in We the both half XXXX. to be expect of these available systems first
number Finally, of we will a XXXX. that in other roll INR out in development projects under have
on more is computer-assisted orthopedic of tremendous. next to these provide long-term information technology potential year. transform surgery will developments The We
and We are aggressively transformation synchronized that investing forefront strategy. to with the Globus remains highly at this integrated ensure a holistic, of
quarters Our performance ability as demonstrates and two tomorrow. and compete share today toward over we to our for capture the past work invest
pipeline by in momentum for to are a and sustained our turnaround growth of XXXX a improved industry-leading quarter our strong in Enabling market-leading driving third introduced EBITDA, Solutions, new performance in poised Musculoskeletal demonstrated we on are product and QX. tap deductions finish summary, Technologies, profitability significantly In is fashion, excited about and record
I Vice to Pfeil, President Senior would Officer. opportunity Financial to take and Chief introduce Keith like our this new
we as XX consumer As a publicly us in after he to CFO. June, years company traded recently announced as Keith where products comes most served
of to successfully pleased team are with with acquisitions and his broaden Senior his analytical addition will driving in making Globus. His Leadership track Keith. role efficiencies We our approach, experience serve integrating of him with his well and record the
by done continue of organization leading years. has from of and I business our grow have Globus. as would expanded to Commercial role and our company flow. outstanding Globus and Scavilla the Officer Dan discipline made the the is exceptional of Dan on for as while CFO Keith continuing our our an we be also job will the of focus Trauma cash addition The financial trauma fiscal to business Chief has recognize producing to contributions operational to for enable the functions as INR his maintaining past within building and of like Dan scope to most four responsible
call over turn now Keith. the will to I
